When do we choose semaglotide and when does terzipatide? EASO has just announced that it will update its algorithm with evidence until November 2025 Warning: It depends on the clinical goal. Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Cagrilintidebrandname" Results on X Live Posts & Updates Semaglutide, Tirzepatide, Retatrutide and Cagrilintide are often lumped together, but they are not doing the same thing. : r Wegovy Recent advances in peptide based therapies for obesity and type 2 diabetes ScienceDirect